Gastrointestinal evaluation ( DrugBank: - )
1 disease
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
78 | Hypopituitarism | 1 |
78. Hypopituitarism
Clinical trials : 494 / Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00227253 (ClinicalTrials.gov) | September 1993 | 14/9/2005 | Chromosome 18 Clinical Research Center | The Chromosome 18 Clinical Research Center | Chromosome Aberrations;Growth Hormone Deficiency;Hypomyelination | Procedure: Determination of growth hormone status;Procedure: Measurement of growth, thyroid and sex hormone levels;Procedure: Behavior and neuropsychometric evaluations;Procedure: Audiological and ear, nose and throat examination;Procedure: Magnetic resonance imaging of the brain;Procedure: Dysmorphology evaluation;Procedure: Neurology examination;Procedure: Dental evaluation;Procedure: Speech pathology evaluation;Procedure: Psychiatric evaluation;Procedure: Orthopedic evaluation;Procedure: Ophthalmologic evaluation;Procedure: Gastrointestinal evaluation | The University of Texas Health Science Center at San Antonio | NULL | Recruiting | N/A | N/A | All | 4000 | United States |